Cambrex Overview
- Year Founded
-
1981

- Status
-
Private
- Employees
-
2,000

- Latest Deal Type
-
Debt - Acquisition
- Financing Rounds
-
8
- Investments
-
12
Cambrex General Information
Description
Provider of drug substance, drug product and analytical services intended to serve the pharmaceutical industry. The company primarily supplies drug substance technologies and capabilities including biocatalysis, application programming interfaces, continuous flow, controlled substances, solid-state science, material characterization in addition to conventional dosage forms including oral solids, semi-solids and liquids and manufactures specialist dosage forms such as modified-release, fixed-dose combination, bi-layer tablets, sterile and non-sterile ointments, enabling pharma companies to accelerate the small molecule therapeutics.
Contact Information
Website
www.cambrex.comCorporate Office
- One Meadowlands Plaza
- East Rutherford, NJ 07073
- United States
Corporate Office
- One Meadowlands Plaza
- East Rutherford, NJ 07073
- United States
Cambrex Timeline
Cambrex Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Cambrex Comparisons
Industry
Financing
Details
Cambrex Competitors (31)
One of Cambrex’s 31 competitors is Nutriband, a Formerly Angel backed company based in Orlando, FL.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Nutriband | Formerly Angel backed | Orlando, FL | ||||
Hovione | Private Equity-Backed | Loures, Portugal | ||||
Novartis | Corporation | Basel, Switzerland | ||||
Cipla | Corporation | Mumbai, India | ||||
Active Iron | Venture Capital-Backed | Cork, Ireland |
Cambrex Patents
Cambrex Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20240239750-A1 | Pharmaceutical preparation | Pending | 05-May-2021 | ||
US-20230339880-A1 | Compositions of ajulemic acid and uses thereof | Pending | 24-Oct-2019 | ||
US-20210393612-A1 | Polymorphic compounds and uses thereof | Active | 02-May-2019 | ||
US-12029735-B2 | Polymorphic compounds and uses thereof | Active | 02-May-2019 | ||
US-11136331-B2 | Methods of o-demethylation | Active | 13-Oct-2017 | C07D489/12 |
Cambrex Signals
Cambrex Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
Cambrex Investments & Acquisitions (12)
Cambrex’s most recent deal was a Buyout/LBO with Snapdragon Chemistry. The deal was made on 18-Jan-2023.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Snapdragon Chemistry | 18-Jan-2023 | Buyout/LBO | BPO/Outsource Services | ||
Q1 Scientific | 01-Jun-2022 | Buyout/LBO | BPO/Outsource Services | ||
Avista Pharma | 02-Jan-2019 | Merger/Acquisition | Other Healthcare Services | ||
Halo Pharmaceutical | 23-Jul-2018 | Merger/Acquisition | Other Pharmaceuticals and Biotechnology | ||
PharmaCore | 07-Oct-2016 | Merger/Acquisition | Other Pharmaceuticals and Biotechnology |
Cambrex Exits (2)
Cambrex’s most recent exit was on 23-Jul-2018 from Halo Pharmaceutical. The exit was categorized as .
Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
---|---|---|---|---|---|
Halo Pharmaceutical | 23-Jul-2018 | Completed |
|
||
CoPharma (United States) | 30-Oct-2001 | Merger/Acquisition | Completed |
Cambrex Affiliates
Subsidiaries (2)
Name | Industry | Location | Year Founded |
---|---|---|---|
Halo Pharmaceutical Canada | Mirabel, Canada | 2018 | |
Q1 Scientific | Waterford, Ireland | 2012 |
Cambrex FAQs
-
When was Cambrex founded?
Cambrex was founded in 1981.
-
Where is Cambrex headquartered?
Cambrex is headquartered in East Rutherford, NJ.
-
What is the size of Cambrex?
Cambrex has 2,000 total employees.
-
What industry is Cambrex in?
Cambrex’s primary industry is Pharmaceuticals.
-
Is Cambrex a private or public company?
Cambrex is a Private company.
-
What is Cambrex’s current revenue?
The current revenue for Cambrex is
. -
How much funding has Cambrex raised over time?
Cambrex has raised $259M.
-
Who are Cambrex’s investors?
Permira and C2I Accelerator have invested in Cambrex.
-
Who are Cambrex’s competitors?
Nutriband, Hovione, Novartis, Cipla, and Active Iron are some of the 31 competitors of Cambrex.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »